Literature DB >> 2250347

[Interactions of radiation and biological response modifiers (BRMs) in the treatment of malignant tumor].

N Mitsuhashi1, M Takahashi, A Okazaki, H Niibe.   

Abstract

This article reports on attempt to characterize the interactions of radiation and BRMs in the treatment of malignant tumor on the basis of our some experimental results. BRMs have a high possibility to enhance radiation effects on tumor cells with in a radiation field and bring some benefits to host tumor immune system with minimizing deleterious effects of irradiation to the immune responses. But it is very difficult to determine the rational design of administration of BRMs to induce the most effective interactions on relevant immune system and other host responses in the combination with radiotherapy. We should make it clear how radiation can be useful to potentiate the tumor antigenecity or antitumor immune responses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250347

Source DB:  PubMed          Journal:  Gan No Rinsho        ISSN: 0021-4949


  1 in total

1.  Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site.

Authors:  T Kazumoto; N Mitsuhashi; K Hayakawa; I Yonome; H Niibe
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.